Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dianon Systems

This article was originally published in The Gray Sheet

Executive Summary

Stock repurchase program is increased by an additional $10 mil. to a total of $11.8 mil. "The company intends to purchase shares from time to time, in its sole discretion, as market conditions warrant in the open market or in privately negotiated transactions," Dianon says. Separately, the company announces that it has formally withdrawn its unsolicited offer to acquire all outstanding shares of UroCor of $7.50 each "in light of our inability to conclude discussions with UroCor on a basis satisfactory to Dianon shareholders." The offer was rejected by UroCor in August ("The Gray Sheet" Aug. 31, In Brief)
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010965

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel